Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma

NCT07129772 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Cancer Recurrent
Nasopharyngeal Cancinoma (NPC)

Interventions

DRUG: Gemcitabine (GEM)
DRUG: Cisplatin
DRUG: PEMBROLIZUMAB (alone or when added to a regimen above)

Sponsor

The University of Hong Kong

Collaborators

[object Object]
[object Object]
[object Object]